Literature DB >> 19260997

Source of transmission in children with chronic hepatitis B infection after the implementation of a strategy for prevention in those at high risk.

Haruki Komatsu1, Ayano Inui, Tsuyoshi Sogo, Eitaro Hiejima, Naoko Kudo, Tomoo Fujisawa.   

Abstract

AIM: In order to clarify the sources of chronic HBV (hepatitis B virus) infection in children after the implementation of an "at-risk" strategy in Japan, chronically infected children were assessed. In addition, chronically infected children born to HBsAg-negative mothers and their family members were assessed to identify the sources of HBV transmission.
METHODS: Fifty-seven children who tested HBsAg-positive after the initiation of a mother-to-child transmission prevention program were enrolled in this study. The full-genome HBV DNA sequence was analyzed to confirm the transmission sources.
RESULTS: Of the 57 patients, 37 (65%) were born to HBV carrier mothers. The remaining 20 (35%) patients were born to HBsAg-negative mothers. Fourteen of these patients had HBV carrier fathers, and 2 patients, who were siblings, did not have an HBV carrier father. The remaining 4 patients had no family members with HBV infection. Phylogenetic tree analysis confirmed that father-to-child transmission and sibling-to-sibling transmission occurred in 3 families and 1 family, respectively.
CONCLUSION: Although vaccine failure of mother-to-child transmission was the major cause of chronic HBV infection in children, father-to-child transmission was the second most common mode of transmission. In addition, sibling-to-sibling transmission was found. Unless at-risk individuals and groups can be accurately identified to prevent horizontal transmission, the introduction of universal vaccination is essential for achieving the elimination of HBV infection in Japan.

Entities:  

Year:  2009        PMID: 19260997     DOI: 10.1111/j.1872-034X.2009.00496.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

1.  Effect of hepatitis B vaccination in hepatitis B surface antibody-negative pregnant mothers on the vertical transmission of hepatitis B virus from father to infant.

Authors:  Li-Hua Cao; Yun-Ru Li; Shou-Yun Wang; Zhi-Min Liu; Shao-Chun Sun; Dong-Bo Xu; Ji-Dong Zhang
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

Review 2.  Barriers to screening for hepatitis B virus infection in Asian Americans.

Authors:  Ke-Qin Hu; Calvin Q Pan; Diane Goodwin
Journal:  Dig Dis Sci       Date:  2011-08-23       Impact factor: 3.199

3.  Efficacy and safety of nucleoside analogs on blocking father-to-infant vertical transmission of hepatitis B virus.

Authors:  Li-Hau Cao; Pei-Li Zhao; Zhi-Min Liu; Shao-Chun Sun; Dong-Bo Xu; Ji-Dong Zhang; Mei-Hua Shao
Journal:  Exp Ther Med       Date:  2015-03-20       Impact factor: 2.447

Review 4.  Vaccine chronicle in Japan.

Authors:  Tetsuo Nakayama
Journal:  J Infect Chemother       Date:  2013-07-09       Impact factor: 2.211

5.  The association of adverse outcomes in the mother with disease progression in offspring in families with clusters of hepatitis B virus infection and unfavorable prognoses in Northwest China.

Authors:  Yuan Yang; Li Jin; Zhen Tian; Dandan Guo; Naijuan Yao; Qian Li; Zicheng Jiang; Daokun Yang; Xianmei Tang; Hongbin Li; Yingli He; Jinfeng Liu; Tianyan Chen; Yingren Zhao
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

6.  Possible Paternal Hepatitis B Virus Infection with Different Clinical Courses between Siblings: A Report of Two Cases.

Authors:  Yoshiaki Sasaki; Hiroki Kajino
Journal:  Case Reports Hepatol       Date:  2022-03-07

7.  The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B.

Authors:  Maito Suoh; Akihiro Tamori; Yuga Amano-Teranishi; Takashi Nakai; Masaru Enomoto; Yasuko Kawasaki; Kiyohide Kioka; Norifumi Kawada
Journal:  Intern Med       Date:  2020-01-15       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.